FULC Annual ROE
-44.84%
+8.69%+16.23%
31 December 2023
Summary:
As of January 23, 2025, FULC annual return on equity is -44.84%, with the most recent change of +8.69% (+16.23%) on December 31, 2023. During the last 3 years, it has risen by +32.84% (+42.28%). FULC annual ROE is now -4.57% below its all-time high of -42.88%, reached on December 31, 2018.FULC ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FULC Quarterly ROE
-7.31%
+0.76%+9.42%
30 September 2024
Summary:
As of January 23, 2025, FULC quarterly return on equity is -7.31%, with the most recent change of +0.76% (+9.42%) on September 30, 2024. Over the past year, it has increased by +31.28% (+81.06%). FULC quarterly ROE is now at all-time high.FULC Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FULC ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.2% | +81.1% |
| 3 y3 years | +42.3% | +81.1% |
| 5 y5 years | -4.6% | +81.1% |
FULC ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +16.2% | at high | +87.3% |
| 5 y | 5-year | at high | +52.7% | at high | +93.2% |
| alltime | all time | -4.6% | +97.4% | at high | +93.2% |
Fulcrum Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -7.31%(-9.4%) |
| June 2024 | - | -8.07%(-79.3%) |
| Mar 2024 | - | -38.96%(+1.0%) |
| Dec 2023 | -44.84%(-16.2%) | -38.59%(-2.5%) |
| Sept 2023 | - | -39.56%(-7.3%) |
| June 2023 | - | -42.69%(-16.2%) |
| Mar 2023 | - | -50.97%(-8.9%) |
| Dec 2022 | -53.53%(+1.5%) | -55.95%(+5.8%) |
| Sept 2022 | - | -52.90%(-8.3%) |
| June 2022 | - | -57.70%(+11.8%) |
| Mar 2022 | - | -51.60%(-0.9%) |
| Dec 2021 | -52.72% | -52.09%(-7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -56.08%(-14.2%) |
| June 2021 | - | -65.36%(-1.9%) |
| Mar 2021 | - | -66.61%(-9.7%) |
| Dec 2020 | -77.68%(-18.1%) | -73.76%(+2.5%) |
| Sept 2020 | - | -71.94%(+2.9%) |
| June 2020 | - | -69.94%(-14.8%) |
| Mar 2020 | - | -82.06%(-23.5%) |
| Dec 2019 | -94.86%(+121.2%) | -107.31%(+5.7%) |
| Sept 2019 | - | -101.56%(-2.7%) |
| June 2019 | - | -104.38%(+18.1%) |
| Mar 2019 | - | -88.36%(+106.1%) |
| Dec 2018 | -42.88%(-97.5%) | -42.88% |
| Dec 2017 | -1737.07% | - |
FAQ
- What is Fulcrum Therapeutics annual return on equity?
- What is the all time high annual ROE for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics annual ROE year-on-year change?
- What is Fulcrum Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics quarterly ROE year-on-year change?
What is Fulcrum Therapeutics annual return on equity?
The current annual ROE of FULC is -44.84%
What is the all time high annual ROE for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high annual return on equity is -42.88%
What is Fulcrum Therapeutics annual ROE year-on-year change?
Over the past year, FULC annual return on equity has changed by +8.69% (+16.23%)
What is Fulcrum Therapeutics quarterly return on equity?
The current quarterly ROE of FULC is -7.31%
What is the all time high quarterly ROE for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high quarterly return on equity is -7.31%
What is Fulcrum Therapeutics quarterly ROE year-on-year change?
Over the past year, FULC quarterly return on equity has changed by +31.28% (+81.06%)